Efficacy and acceptability of long-term norethindrone acetate for the treatment of rectovaginal endometriosis

Matteo Morotti, Pier Luigi Venturini, Ennio Biscaldi, Annalisa Racca, Luana Calanni, Valerio Gaetano Vellone, Cesare Stabilini, Simone Ferrero
European journal of obstetrics, gynecology, and reproductive biology · 2017 · vol. 213 , pp. 4–10 · doi:10.1016/j.ejogrb.2017.03.033 · PMID:28384540 · W2602194673
article OA: closed CC0 ⤵ 29 in-corpus citations
Limited metadata. Only one source feed has indexed this record so far — no abstract, full text, or open-access copy is available through Endo Lab. The publisher's page (linked below) is the canonical location for the actual content. If you have institutional access, use "Find at my library".
View at publisher → View on OpenAlex View on PubMed
⚙ AI-generated summary by claude@2026-06, 2026-06-07 ⓘ

This study evaluated the long-term efficacy and acceptability of norethindrone acetate in treating rectovaginal endometriosis.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

My notes (saved in your browser only)

Condition tags

dyspareuniaendometriosischronic_pelvic_painbowel_endometriosis

MeSH descriptors

Endometriosis Norethindrone Rectal Diseases Vaginal Diseases Adult Cohort Studies Dyspareunia Dyspareunia Endometriosis Endometriosis Endometriosis Female Humans Norethindrone Norethindrone Norethindrone Acetate Pain Measurement Patient Satisfaction Pelvic Pain Pelvic Pain

Citation neighborhood

Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. [ expand to 2 hops ] — adds papers reached through this work's immediate citers/citees. Heavier; up to 60 extra dots.

References (37)

Cited by (29)

Source provenance

europepmc
last seen: 2026-06-12T06:13:51.797165+00:00
openalex
last seen: 2026-06-10T17:14:06.276822+00:00
pubmed
last seen: 2026-05-13T22:20:31.759405+00:00
License: CC0 · commercial use OK